The Kansas City Cardiomyopathy Questionnaire (KCCQ) -: A new disease-specific quality of life measure for patients with chronic heart failure psychometric evaluation of the German version

被引:53
作者
Faller, H
Steinbüchel, T
Schowalter, M
Spertus, JA
Störk, S
Angermann, CE
机构
[1] Univ Wurzburg, Inst Psychotherapie & Med Psychol, D-97070 Wurzburg, Germany
[2] Univ Missouri, Kansas City, KS USA
[3] Mid Amer Heart Inst, Kansas City, MO USA
[4] Univ Wurzburg, Med Poliklin, D-8700 Wurzburg, Germany
关键词
quality of life; chronic heart failure; psychometric evaluation; Kansas City Cardiomyopathy Questionnaire;
D O I
10.1055/s-2004-834597
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Patients' health-related quality of life is increasingly being included as an additional endpoint when evaluating the treatment of chronic heart failure. Although generic self-report instruments measuring health-related quality of life are available, there is a lack of disease-specific instruments covering various dimensions of quality of life with high reliability, validity and sensitivity to chance. Thus, the aim of the present study was to evaluate the German version of a new heart failure-specific quality of life measure, the Kansas City Cardiomyopathy Questionnaire (KCCQ). The sample consisted of 233 consecutively recruited outpatients of a university department in Germany. Test-retest-reliability was high (intraclass correlation coefficient 0.93 for both the Functional State and the Clinical Summary total scores). Construct validity was demonstrated with strong correlations to respective subscales of the SF-36. Known groups validity was shown by both statistically and clinically significant differences between NYHA classes. The examination of sensitivity to change yielded promising results. The questionnaire was well accepted by the participating patients. The KCCQ proved to be a reliable and valid self-report instrument for measuring disease-specific quality of life in chronic heart failure.
引用
收藏
页码:200 / 208
页数:9
相关论文
共 46 条
  • [1] Acquadro C, 1996, Quality of life and pharmacoeconomics in clinical trials, P575
  • [2] Self-rating of quality of life provides additional prognostic information in heart failure.: Insights into the EPICAL study
    Alla, F
    Briançon, S
    Guillemin, F
    Juillière, Y
    Mertès, PM
    Villemot, JP
    Zannad, F
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2002, 4 (03) : 337 - 343
  • [3] [Anonymous], 1998, SF 36 FRAGEBOGEN GES
  • [4] [Anonymous], PSYCHOONCOLOGY
  • [5] [Anonymous], 2000, Z F R MEDIZINISCHE P
  • [6] Discriminant properties of commonly used quality of life measures in heart failure
    Bennett, SJ
    Oldridge, NB
    Eckert, GJ
    Embree, JL
    Browning, S
    Hou, N
    Deer, M
    Murray, MD
    [J]. QUALITY OF LIFE RESEARCH, 2002, 11 (04) : 349 - 359
  • [7] Berlin R B Jr, 2001, Congest Heart Fail, V7, P13, DOI 10.1111/j.1527-5299.2001.00863.x
  • [8] A review of quality-of-life evaluations in patients with congestive heart failure
    Berry, C
    McMurray, J
    [J]. PHARMACOECONOMICS, 1999, 16 (03) : 247 - 271
  • [9] Bullinger M, 1997, PSYCHOTHER PSYCH MED, V47, P76
  • [10] Bullinger M., 1996, Q. Life Pharmac. Clin. Trials, V24, P659